Cargando…
Optimal Clinical Management and the Molecular Biology of Angiosarcomas
SIMPLE SUMMARY: Angiosarcomas are a group of a rare vascular cancers transformed from endothelial cells that could occur in any body part. Most angiosarcomas have unknown aetiology but secondary angiosarcomas could occur after radiation exposure or chronic lymphedema. The optimal treatment for local...
Autores principales: | Chen, Tom Wei-Wu, Burns, Jessica, Jones, Robin L., Huang, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696056/ https://www.ncbi.nlm.nih.gov/pubmed/33182685 http://dx.doi.org/10.3390/cancers12113321 |
Ejemplares similares
-
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update
por: Young, Robin J., et al.
Publicado: (2017) -
Current understanding of angiosarcoma: disease biology and evolving treatment
por: Kim, Woo Ju, et al.
Publicado: (2023) -
Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma
por: Tsuruta, James K., et al.
Publicado: (2017) -
Imaging features of primary sites and metastatic patterns of angiosarcoma
por: Bhaludin, Basrull N., et al.
Publicado: (2021) -
Systemic therapy in primary angiosarcoma of the spleen
por: Ferreira, Bruna Pellini, et al.
Publicado: (2012)